This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Genentech USA, Inc., a biotechnology company and manufacturer of pharmaceuticals based in South San Francisco, California. The contract is for the supply of oseltamivir phosphate, an antiviral medication, with a ceiling value of $87,034.98. The contract is a firm-fixed-price delivery order that was awarded on September 28, 2016, with a completion date of September 28, 2017. The contract was not set aside for any small business category. Genentech USA, Inc. is a foreign-owned, for-profit organization that manufactures and supplies a range of pharmaceutical products, including biologics and medical supplies, to various federal agencies through multiple contract vehicles, such as a $4.9 billion Federal Supply Schedule with the Department of Veterans Affairs and a $27.9 million indefinite delivery contract with the DLA.